Joseph Van Tuyl Associate Professor, Pharmacy Practice Pharmacy Practice Joseph.VanTuyl@uhsp.edu 314.446.8171 Education Doctor of Pharmacy - University of Oklahoma College of Pharmacy PGY1 Pharmacy Residency - University of Oklahoma College of Pharmacy PGY2 Cardiology Residency - University of North Carolina Hospital Specialty Cardiology Current Research Dr. Van Tuyl's research focuses on pharmacologic therapy in structure heart disease, acute heart failure, and mechanical circulatory support. His ongoing research includes an evaluation of the effect of bariatric surgery on the effectiveness of medications for secondary prevention of coronary artery disease and an assessment of renin-angiotensin-aldosterone antagonists on cardiac reverse remodeling after transcatheter aortic valve replacement. Vita Highlights Publications Jones TW, Smith SE, Van Tuyl J, Newsome AS. Sepsis with pre-existing heart failure: management of confounding clinical features. J Intensive Care Med. 2020; doi:10.1177/0885066620928299. Van Tuyl JS, Newsome AS, Hollis IB. Perioperative bridging with glycoprotein IIb/IIIa inhibitors versus cangrelor: balancing efficacy and safety. Ann Pharmacother. 2019;53(7):726-37. Vouri SM, Van Tuyl JS, Olsen MA, Xian H, Schootman M. An evaluation of a potential calcium channel blocker – lower extremity edema – loop diuretic prescribing cascade. J Am Pharm Assoc. 2018;58(5):534-539. Van Tuyl JS, Hollis IB, Alburikan KA, Tran R, Murray BP, Rodgers JE, Katz JN, Sheridan BC. Warfarin and aspirin versus warfarin alone for prevention of embolic events in patients with a HeartMate II® left ventricular assist device. ASAIO J. 2017;63(6):731-5.
Doctor of Pharmacy - University of Oklahoma College of Pharmacy
PGY1 Pharmacy Residency - University of Oklahoma College of Pharmacy
PGY2 Cardiology Residency - University of North Carolina Hospital
Cardiology
Dr. Van Tuyl's research focuses on pharmacologic therapy in structure heart disease, acute heart failure, and mechanical circulatory support. His ongoing research includes an evaluation of the effect of bariatric surgery on the effectiveness of medications for secondary prevention of coronary artery disease and an assessment of renin-angiotensin-aldosterone antagonists on cardiac reverse remodeling after transcatheter aortic valve replacement.
Publications
Jones TW, Smith SE, Van Tuyl J, Newsome AS. Sepsis with pre-existing heart failure: management of confounding clinical features. J Intensive Care Med. 2020; doi:10.1177/0885066620928299.
Van Tuyl JS, Newsome AS, Hollis IB. Perioperative bridging with glycoprotein IIb/IIIa inhibitors versus cangrelor: balancing efficacy and safety. Ann Pharmacother. 2019;53(7):726-37.
Vouri SM, Van Tuyl JS, Olsen MA, Xian H, Schootman M. An evaluation of a potential calcium channel blocker – lower extremity edema – loop diuretic prescribing cascade. J Am Pharm Assoc. 2018;58(5):534-539.
Van Tuyl JS, Hollis IB, Alburikan KA, Tran R, Murray BP, Rodgers JE, Katz JN, Sheridan BC. Warfarin and aspirin versus warfarin alone for prevention of embolic events in patients with a HeartMate II® left ventricular assist device. ASAIO J. 2017;63(6):731-5.